Susquehanna International Group, LLP Inmune Bio, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$7.15 - $11.84 $281,710 - $466,496	39,400 New	39,400 $347,000
Q4 2023 Feb 14, 2024	SELL	$6.6 - $11.52 $93,060 - $162,432	-14,100 Reduced 36.43%	24,600 $276,000
Q3 2023 Nov 14, 2023	BUY	$6.61 - $10.9 $32,389 - $53,410	4,900 Added 14.5%	38,700 $261,000
Q2 2023 Aug 11, 2023	BUY	$6.5 - $10.09 $219,700 - $341,042	33,800 New	33,800 $306,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $10.44 $118,384 - $204,624	19,600 New	19,600 $122,000

5.88M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $89M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.